Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report.

Strik, Anne S; D'Haens, Geert R; Löwenberg, Mark

Strik, Anne S; D'Haens, Geert R; Löwenberg, Mark.

Afiliação

Strik AS; Department of Gastroenterology and Hepatology, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.

Clin Case Rep ; 7(11): 2049-2053, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31788249

Palavras-chave

gastroenterology and hepatology; hematology; pharmacology; toxicology

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google